558 related articles for article (PubMed ID: 29145357)
21. Status of New Vaccine Introduction - Worldwide, September 2016.
Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
[TBL] [Abstract][Full Text] [Related]
22. Routine Vaccination Coverage - Worldwide, 2019.
Chard AN; Gacic-Dobo M; Diallo MS; Sodha SV; Wallace AS
MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(45):1706-1710. PubMed ID: 33187395
[TBL] [Abstract][Full Text] [Related]
23. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
Causey K; Fullman N; Sorensen RJD; Galles NC; Zheng P; Aravkin A; Danovaro-Holliday MC; Martinez-Piedra R; Sodha SV; Velandia-González MP; Gacic-Dobo M; Castro E; He J; Schipp M; Deen A; Hay SI; Lim SS; Mosser JF
Lancet; 2021 Aug; 398(10299):522-534. PubMed ID: 34273292
[TBL] [Abstract][Full Text] [Related]
24. Forecasted trends in vaccination coverage and correlations with socioeconomic factors: a global time-series analysis over 30 years.
de Figueiredo A; Johnston IG; Smith DM; Agarwal S; Larson HJ; Jones NS
Lancet Glob Health; 2016 Oct; 4(10):e726-35. PubMed ID: 27569362
[TBL] [Abstract][Full Text] [Related]
25. Routine Vaccination Coverage - Worldwide, 2021.
Rachlin A; Danovaro-Holliday MC; Murphy P; Sodha SV; Wallace AS
MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1396-1400. PubMed ID: 36327156
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with routine immunization coverage of children under one year old in Lao People's Democratic Republic.
Phoummalaysith B; Yamamoto E; Xeuatvongsa A; Louangpradith V; Keohavong B; Saw YM; Hamajima N
Vaccine; 2018 May; 36(19):2666-2672. PubMed ID: 29606518
[TBL] [Abstract][Full Text] [Related]
27. Progress Toward Measles Elimination - Pakistan, 2000-2018.
Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
[TBL] [Abstract][Full Text] [Related]
28. Routine Vaccination Coverage - Worldwide, 2022.
Kaur G; Danovaro-Holliday MC; Mwinnyaa G; Gacic-Dobo M; Francis L; Grevendonk J; Sodha SV; Sugerman C; Wallace A
MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(43):1155-1161. PubMed ID: 37883326
[TBL] [Abstract][Full Text] [Related]
29. The Challenge of Achieving Immunity Through Multiple-Dose Vaccines in Madagascar.
Jones FK; Mensah K; Heraud JM; Randriatsarafara FM; Metcalf CJE; Wesolowski A
Am J Epidemiol; 2021 Oct; 190(10):2085-2093. PubMed ID: 34023892
[TBL] [Abstract][Full Text] [Related]
30. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
Chauke-Moagi BE; Mumba M
Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
[TBL] [Abstract][Full Text] [Related]
31. Diphtheria in the WHO European Region, 2010 to 2019.
Muscat M; Gebrie B; Efstratiou A; Datta SS; Daniels D
Euro Surveill; 2022 Feb; 27(8):. PubMed ID: 35209973
[TBL] [Abstract][Full Text] [Related]
32. Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria.
Utazi CE; Aheto JMK; Wigley A; Tejedor-Garavito N; Bonnie A; Nnanatu CC; Wagai J; Williams C; Setayesh H; Tatem AJ; Cutts FT
Vaccine; 2023 Jan; 41(1):170-181. PubMed ID: 36414476
[TBL] [Abstract][Full Text] [Related]
33. Progress towards measles elimination in Eritrea: 2003 - 2018.
Yehdego T; Yhdego TK; Masresha B; Gebreslassie A; Katsande R; Fussum D; Lebo E; Namboze J
Pan Afr Med J; 2020; 35(Suppl 1):7. PubMed ID: 32373258
[TBL] [Abstract][Full Text] [Related]
34. The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plans.
Daugherty MA; Hinman AR; Cochi SL; Garon JR; Rodewald LE; Nowak G; McKinlay MA; Mast EE; Orenstein WA
Vaccine; 2019 Aug; 37(35):4928-4936. PubMed ID: 31326253
[TBL] [Abstract][Full Text] [Related]
35. Progress in global measles control, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(4):73-8. PubMed ID: 22298303
[TBL] [Abstract][Full Text] [Related]
36. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
[TBL] [Abstract][Full Text] [Related]
37. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
[TBL] [Abstract][Full Text] [Related]
38. Global routine vaccination coverage, 2014.
Wkly Epidemiol Rec; 2015 Nov; 90(46):617-23. PubMed ID: 26567398
[No Abstract] [Full Text] [Related]
39. Measles control in Sub-Saharan Africa: South Africa as a case study.
Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
[TBL] [Abstract][Full Text] [Related]
40. Short term evaluation of a rural immunization program in Nigeria.
Odusanya OO; Alufohai JE; Meurice FP; Clemens R; Ahonkhai VI
J Natl Med Assoc; 2003 Feb; 95(2):175-9. PubMed ID: 12760613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
